Published in Brain Res on December 20, 2002
Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood brain barrier disruption after experimental stroke. Ther Hypothermia Temp Manag (2013) 0.82
Intracerebral hemorrhage in mouse models: therapeutic interventions and functional recovery. Metab Brain Dis (2014) 0.76
Evidence for Decreased Brain Parenchymal Volume After Large Intracerebral Hemorrhages: a Potential Mechanism Limiting Intracranial Pressure Rises. Transl Stroke Res (2017) 0.75
Examining potential side effects of therapeutic hypothermia in experimental intracerebral hemorrhage. J Cereb Blood Flow Metab (2016) 0.75
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70
Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol (2006) 10.51
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke (2007) 2.93
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke (2008) 2.39
Research into neuroprotection must continue ... But with a different approach. Stroke (2008) 2.36
Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab (2007) 2.07
Endothelial progenitor cells during cerebrovascular disease. Stroke (2004) 2.04
Atrial myxoma as a cause of stroke: case report and discussion. CMAJ (2003) 1.82
Initial lesion volume is an independent predictor of clinical stroke outcome at day 90: an analysis of the Virtual International Stroke Trials Archive (VISTA) database. Stroke (2012) 1.79
Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke (2007) 1.75
Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index. Stroke (2004) 1.66
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation (2003) 1.63
Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis (2011) 1.53
Telestroke in Northern Alberta: a two year experience with remote hospitals. Can J Neurol Sci (2010) 1.53
Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol (2002) 1.51
Cervical arterial dissection: time for a therapeutic trial? Stroke (2003) 1.47
Autoregulation of cerebral blood flow is preserved in primary intracerebral hemorrhage. Stroke (2013) 1.41
Thrombolysis in stroke despite contraindications or warnings? Stroke (2013) 1.40
Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times (ESCAPE) trial: methodology. Int J Stroke (2014) 1.38
Laser speckle contrast imaging of collateral blood flow during acute ischemic stroke. J Cereb Blood Flow Metab (2010) 1.34
The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation. Can J Cardiol (2003) 1.25
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines. Can J Cardiol (2011) 1.25
Constraint-induced movement therapy and rehabilitation exercises lessen motor deficits and volume of brain injury after striatal hemorrhagic stroke in rats. Stroke (2003) 1.22
Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway. J Biol Chem (2005) 1.22
Rodent models of intracerebral hemorrhage. Stroke (2010) 1.18
The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies. J Neuroimaging (2013) 1.14
Effect of hyperthermia on prognosis after acute ischemic stroke. Stroke (2009) 1.14
Therapeutic strategies for the treatment of stroke. Drug Discov Today (2006) 1.12
Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc (2009) 1.12
Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp Neurol (2006) 1.11
Use of prolonged hypothermia to treat ischemic and hemorrhagic stroke. J Neurotrauma (2009) 1.11
Effects of minocycline alone and in combination with mild hypothermia in embolic stroke. Brain Res (2003) 1.10
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial. Stroke (2013) 1.10
Temperature-regulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes. Stroke (2004) 1.09
Delayed minocycline but not delayed mild hypothermia protects against embolic stroke. BMC Neurol (2002) 1.08
Foville's syndrome masquerading as Wernicke's encephalopathy. N Z Med J (2006) 1.08
Gauging recovery after hemorrhagic stroke in rats: implications for cytoprotection studies. J Cereb Blood Flow Metab (2005) 1.06
Safety and feasibility of collateral blood flow augmentation after intravenous thrombolysis. Stroke (2011) 1.06
Comparison of 12, 24 and 48 h of systemic hypothermia on outcome after permanent focal ischemia in rat. Exp Neurol (2008) 1.05
Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study. Stroke (2006) 1.04
Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA collaboration. Stroke (2009) 1.04
Case management for blood pressure and lipid level control after minor stroke: PREVENTION randomized controlled trial. CMAJ (2014) 1.03
Impact of disability status on ischemic stroke costs in Canada in the first year. Can J Neurol Sci (2012) 1.01
The influence of hypothermia on outcome after intracerebral hemorrhage in rats. Stroke (2006) 1.01
Delayed onset of prolonged hypothermia improves outcome after intracerebral hemorrhage in rats. J Cereb Blood Flow Metab (2004) 1.01
Endothelial progenitor cells and cerebrovascular diseases. Prog Neurobiol (2007) 1.00
Critical role of microvasculature basal lamina in ischemic brain injury. Prog Neurobiol (2007) 1.00
Current and future concepts in stroke prevention. CMAJ (2004) 0.99
Treatment of intracerebral hemorrhage in rats with 12 h, 3 days and 6 days of selective brain hypothermia. Exp Neurol (2009) 0.99
Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial. Stroke (2006) 0.99
Treatments (12 and 48 h) with systemic and brain-selective hypothermia techniques after permanent focal cerebral ischemia in rat. Exp Neurol (2009) 0.98
High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis (2006) 0.98
A critical appraisal of experimental intracerebral hemorrhage research. J Cereb Blood Flow Metab (2012) 0.97
Circulating endothelial progenitor cells and age-related white matter changes. Stroke (2009) 0.97
Failure of deferoxamine, an iron chelator, to improve outcome after collagenase-induced intracerebral hemorrhage in rats. Brain Res (2009) 0.96
Elevations of diffusion anisotropy are associated with hyper-acute stroke: a serial imaging study. Magn Reson Imaging (2008) 0.96
Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke. Brain Res (2005) 0.95
Neuroprotective effects of free radical scavengers in stroke. Drugs Aging (2007) 0.94
Partial intra-aortic occlusion improves perfusion deficits and infarct size following focal cerebral ischemia. J Neuroimaging (2009) 0.94
How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke (2002) 0.94
Use of telemetry blood pressure transmitters to measure intracranial pressure (ICP) in freely moving rats. Curr Neurovasc Res (2009) 0.93
Ferric iron chelation lowers brain iron levels after intracerebral hemorrhage in rats but does not improve outcome. Exp Neurol (2011) 0.92
Oxfordshire community stroke project classification poorly differentiates small cortical and subcortical infarcts. Stroke (2011) 0.91
Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis. J Cereb Blood Flow Metab (2008) 0.91
Brain temperature measurement and regulation in awake and freely moving rodents. Methods (2003) 0.91
Rehabilitation after intracerebral hemorrhage in rats improves recovery with enhanced dendritic complexity but no effect on cell proliferation. Behav Brain Res (2010) 0.91
Skilled reaching impairments follow intrastriatal hemorrhagic stroke in rats. Behav Brain Res (2006) 0.91
Long-term assessment of motor and cognitive behaviours in the intraluminal perforation model of subarachnoid hemorrhage in rats. Behav Brain Res (2008) 0.90
NMDA/NR2B selective antagonists in the treatment of ischemic brain injury. Curr Drug Targets CNS Neurol Disord (2005) 0.90
Effects of hyperthermia on infarct volume in focal embolic model of cerebral ischemia in rats. Neurosci Lett (2003) 0.90
A robust, efficient and flexible method for staining myelinated axons in blocks of brain tissue. J Neurosci Methods (2003) 0.90
Sodium imaging intensity increases with time after human ischemic stroke. Ann Neurol (2009) 0.88
The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary. Can J Cardiol (2011) 0.88
Emergency department or general practitioner following transient ischaemic attack? A comparison of patient behaviour and speed of assessment in England and Canada. Emerg Med J (2010) 0.88
The relationship between diffusion anisotropy and time of onset after stroke. J Cereb Blood Flow Metab (2006) 0.88
A simple method to induce focal brain hypothermia in rats. J Cereb Blood Flow Metab (2006) 0.88
Prolonged therapeutic hypothermia does not adversely impact neuroplasticity after global ischemia in rats. J Cereb Blood Flow Metab (2012) 0.87
Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats. J Cereb Blood Flow Metab (2009) 0.87
Prognostic evaluation based on cortical vein score difference in stroke. Stroke (2013) 0.87
Favorable vascular profile is an independent predictor of outcome: a post hoc analysis of the safety and efficacy of NeuroFlo Technology in Ischemic Stroke trial. Stroke (2013) 0.86
Forced exercise does not improve recovery after hemorrhagic stroke in rats. Brain Res (2006) 0.86
Delayed detection of atrial fibrillation after ischemic stroke. J Stroke Cerebrovasc Dis (2009) 0.86
Worldwide reported use of IV tissue plasminogen activator for acute ischemic stroke. Int J Stroke (2013) 0.85
Therapeutic hypothermia influences cell genesis and survival in the rat hippocampus following global ischemia. J Cereb Blood Flow Metab (2011) 0.85
Progressive brain damage and alterations in dendritic arborization after collagenase-induced intracerebral hemorrhage in rats. Curr Neurovasc Res (2008) 0.85
The effects of selective brain hypothermia on intracerebral hemorrhage in rats. Exp Neurol (2007) 0.85
Effects of age on outcome in the SENTIS trial: better outcomes in elderly patients. Cerebrovasc Dis (2012) 0.85
A high fat diet does not exacerbate CA1 injury and cognitive deficits following global ischemia in rats. Brain Res (2008) 0.85
Intra-parenchymal ferrous iron infusion causes neuronal atrophy, cell death and progressive tissue loss: implications for intracerebral hemorrhage. Exp Neurol (2012) 0.85
Adherence to practice guidelines for transient ischemic attacks in an emergency department. Can J Neurol Sci (2002) 0.84
Mild to moderate hyperthermia does not worsen outcome after severe intracerebral hemorrhage in rats. J Cereb Blood Flow Metab (2005) 0.83
Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke. Stroke (2013) 0.83
Immediate constraint-induced movement therapy causes local hyperthermia that exacerbates cerebral cortical injury in rats. Can J Physiol Pharmacol (2004) 0.83
Home time is extended in patients with ischemic stroke who receive thrombolytic therapy: a validation study of home time as an outcome measure. Stroke (2011) 0.82
Expression of tumor necrosis factor alpha and its mRNA in the spinal cord following a weight-drop injury. Neuroreport (2002) 0.81
Effect of zinc in ischemic brain injury in an embolic model of stroke in rats. Neurosci Lett (2004) 0.81
Incomplete assessment of experimental cytoprotectants in rodent ischemia studies. Can J Neurol Sci (2003) 0.81